The fast-paced environment of biomedical research demands a more nimble technology to modify the genetics of model organisms. AVA has developed a Direct, Rapid, and Precise (DRAP) technology to modify the genomes of experimental living systems via homologous recombination. DRAP is a universal recombinase that eliminates the requirement for complex protein engineering to accomplish DNA targeting. DRAP delivers unmatched precision and flexibility to introduce, delete, or tactically modify genomic sequences.